HEMATOLOGIC MALIGNANCIES: TREATMENT
| Issue | Title | File | |
| Vol 20, No 4 (2025) | Efficacy of daratumumab as monotherapy or in combination with antitumor drugs in patients with relapsed / refractory multiple myeloma depending on the previous chemotherapy lines number |
 (Rus) |
|
| Belousov K.A., Mitina T.A., Trifonova E.V., Chernykh Y.B., Zakharov S.G., Kataeva E.V., Vysotskaya L.L., Kharasova Z.M., Vardanyan R.V., Madzyara O.P., Voroshkevich A.A. | |||
| Vol 20, No 4 (2025) | Aggregated experience with the use of mosunetuzumab for the treatment of relapsed / refractory follicular lymphoma in Russia: four centers experience |
(Rus) |
|
| Butaev L.S., Sannikova M.A., Krylova Y.V., Vlasova S.V., Babaeva F.E., Sychevskaya K.A., Zherebtsova V.A., Urnova E.S., Bulusov M.P., Kravchenko S.K., Kruchinkina Y.A., Lapin V.A., Kulagin A.D., Mikhaylova N.B., Ptushkin V.V. | |||
| Vol 20, No 4 (2025) | The significance of CD20 expression in adult patients with BCR::ABL1-negative acute B-cell lymphoblastic leukemia treated according to RALL-2016 protocol |
(Rus) |
|
| Aleshina O.A., Kotova E.S., Galtseva I.V., Chabaeva Y.A., Dvirnyk V.N., Parovichnikova E.N. | |||
| Vol 20, No 4 (2025) | Multiple myeloma: a retrospective analysis of clinical outcomes based on the patient registry of the Moscow City Clinical Hospital No. 52 (2022–2025) |
(Rus) |
|
| Misyurina E.N., Zotina E.N., Gadzhieva S.M., Chernova N.G., Karimova E.A., Zhelnova E.I., Baryakh E.A., Makeshova A.B., Maryin D.S., Zakharov O.D., Tolstykh T.N., Yakimets V.N., Grishina E.Y., Mingalimov M.A., Chudnova T.S., Polyakov D.S., Badaev R.S., Khordzhasov L.O., Zinchuk A.A., Kondratev V.I., Kochneva O.L., Ivanova D.D., Shimanovskaya L.T., Lebedev D.V., Sarakaeva Z.T., Savosina N.A., Yatskov K.V., Mamaeva E.A., Makunina E.A., Orlova M.S., Lysenko M.A., Kotenko O.N., Frolova N.F., Rukavitsyn O.A., Nekrasova A.V., Semina T.A., Lysenko M.A. | |||
| Vol 20, No 3 (2025) | Molecular phenotype of diffuse large B-cell lymphoma as a basis for a personalized treatment approach of elderly patients |
(Rus) |
|
| Mingalimov M.A., Baryakh E.A., Misyurin A.V., Kesaeva L.A., Mkrtchyan A.S., Misyurina E.N., Donskoy M.A., Tolstykh T.N., Orlova M.S., Chudnova T.S., Ivanova D.D., Kochneva O.L., Zotina E.N., Makeshova A.B., Andreev S.S., Lebedev D.V., Yatskov K.V., Samsonova I.V., Lysenko M.A. | |||
| Vol 20, No 3 (2025) | Experience with acalabrutinib as a component of molecularly adapted antitumor therapy according to the R-CHOP-X protocol in patients with newly diagnosed diffuse large B-cell lymphoma |
(Rus) |
|
| Mingalimov M.A., Baryak E.A., Misyurin A.V., Kesaeva L.A., Mkrtchyan A.S., Misyurina E.N., Donskoy M.A., Tolstykh T.N., Orlova M.S., Chudnova T.S., Ivanova D.D., Kochneva O.L., Zotina E.N., Makeshova A.B., Andreev S.S., Yatskov K.V., Samsonova I.V., Lysenko M.A. | |||
| Vol 20, No 3 (2025) | Efficacy of the nivolumab + AVD regimen in the treatment of newly diagnosed classical Hodgkin’s lymphoma: Leningrad Regional Clinical Hospital experience |
(Rus) |
|
| Ulyanova M.A., Vorob’ev V.I., Semochkin S.V., Vinogradova Y.N., Basmanova V.V., Bekoev R.D., Ganzin M.I., Grishko V.S., Sabitova R.R., Tsyrenzhabe T.B., Uspenskaya O.S., Alekseev S.M. | |||
| Vol 20, No 2 (2025) | Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms |
(Rus) |
|
| Vinogradova O.Y., Neverova A.L., Chernikov M.V., Kosenkova V.P., Pankrashkina M.M., Shikhbabaeva D.I., Vekua A.R., Ptushkin V.V. | |||
| Vol 20, No 1 (2025) | Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children |
(Rus) |
|
| Simavonyan Z.K., Valiev T.T., Ryabukhina Y.E., Zeynalova P.A. | |||
| Vol 20, No 1 (2025) | Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data |
(Rus) |
|
| Popova A.V., Solovev M.V., Abakumova A.V., Arutyunyan N.K., Soloveva M.V., Startsev A.A., Mendeleeva L.P. | |||
| Vol 19, No 4 (2024) | Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol |
(Rus) |
|
| Shervashidze M.A., Smirnova D.S., Valiev T.T., Batmanova N.A. | |||
| Vol 19, No 4 (2024) | Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia |
(Rus) |
|
| Vinogradova O.Y., Pankrashkina M.M., Mukha L.A., Neverova A.L., Chernikov M.V., Ptushkin V.V. | |||
| Vol 19, No 4 (2024) | The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol |
(Rus) |
|
| Valiev T.T., Shervashidze M.A., Osipova I.V., Burlutskaya T.I., Aleskerova G.A., Yuldasheva S.N., Sabantsev S.L., Paina O.V., Batmanova N.A., Zubarovskaya L.S., Kirgizov K.I., Varfolomeeva S.R. | |||
| Vol 19, No 4 (2024) | Treatment of elderly patients with acute myeloid leukemia: personal experience |
(Rus) |
|
| Shimanovskaya L.T., Misyurina E.N., Baryakh E.A., Zhelnova E.I., Yatskov K.V., Chudnova T.S., Tolstykh T.N., Gagloeva D.E. | |||
| Vol 19, No 1 (2024) | Very good partial remission predicts progression-free survival in patients with multiple myeloma |
(Rus) |
|
| Luchinin A.S., Semochkin S.V. | |||
| Vol 19, No 1 (2024) | How we treat polycythemia vera |
(Rus) |
|
| Shuvaev V.A., Martynkevich I.S. | |||
| Vol 19, No 1 (2024) | The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation |
(Rus) |
|
| Valiev T.T., Khachatryan A.A., Goryacheva S.V., Batmanova N.A., Kirgizov K.I., Varfolomeeva S.R. | |||
| Vol 18, No 4 (2023) | Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma |
(Rus) |
|
| Semochkin S.V., Lunin V.V., Vernyuk М.А., Fedenko А.А. | |||
| Vol 18, No 4 (2023) | Clinical case of giant extramedullar plasmacytoma in a patient with multiple myeloma |
(Rus) |
|
| Safuanova G.S., Mansurova Y.R., Latypova A.A., Bagautdinova А.U., Rozhenkova T.Y., Valiakhmetova C.K. | |||
| Vol 18, No 4 (2023) | Combination of lymphoproliferative diseases and pregnancy |
(Rus) |
|
| Chernyshova A.L., Chernyakov A.A., Popova N.O., Kravchuk T.L., Trushchuk Y.M., Dil’ O.S., Krasil’nikov S.E., Antipov V.A., Shumeykina A.O. | |||
| Vol 18, No 3 (2023) | Follicular lymphoma in children and adolescents: clinical, diagnostic and therapeutic features |
(Rus) (Eng) |
|
| Valiev T.T., Volkova A.S., Postoykina M.A., Abramov D.S., Karibova A.R., Odzharova A.A., Ryabukhina Y.E., Zeynalova P.A. | |||
| Vol 18, No 3 (2023) | Use of locally produced anti-CD19 CAR-T cells in the treatment of relapsed/refractory B-cell lymphomas in adults |
(Rus) |
|
| Konoplya N.E., Kalenik O.A., Severin I.N., Savritskaya A.A., Bobrova N.M., Doroshenko T.M., Portyanko A.S. | |||
| Vol 18, No 2 (2023) | Differentiated, immunobased approach of anaplastic large cell lymphoma treatment in children and adolescents: literature review and protocol ALCL-NII DOG-2003 results |
(Rus) |
|
| Volkova A.S., Valiev T.T. | |||
| Vol 18, No 2 (2023) | Immune checkpoint inhibitors in pediatric hematologic malignancies |
(Rus) |
|
| Gribkova I.V. | |||
| Vol 18, No 2 (2023) | Treatment of pediatric relapsed and refractory acute myeloid leukemia |
(Rus) |
|
| Makhacheva F.A., Valiev T.T. | |||
| Vol 18, No 1 (2023) | Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience |
(Rus) |
|
| Granatkin M.A., Nikitin E.A., Kislova M.I., Mikhailov E.S., Doronin V.A., Minenko S.V., Okuneva M.M., Antonova A.V., Degtyareva N.V., Pochtar M.E., Lugovskaya S.A., Kobzev Y.N., Ptushkin V.V., Rimashevskaya E.V. | |||
| Vol 18, No 1 (2023) | Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial |
(Rus) |
|
| Aleshina O.A., Galtseva I.V., Kotova E.S., Isinova G.I., Obukhova T.N., Dvirnik V.N., Sudarikov A.B., Grishunina M.E., Samoilova O.S., Kaplanov K.D., Lapin V.A., Bondarenko S.N., Fokina E.S., Minaeva N.V., Konstantinova T.S., Sveshnikova Y.V., Zinina E.E., Antipova A.S., Baranova O.Y., Borisenkova E.A., Davydova Y.O., Kapranov N.M., Kulikov S.M., Chabaeva Y.A., Troitskaya V.V., Parovichnikova E.N. | |||
| Vol 17, No 4 (2022) | A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with transformation into diffuse large B-cell lymphoma (Richter’s syndrome) |
(Rus) |
|
| Rukavitsyn O.A., Pop V.P., Drozd M.V., Ryabukhina Y.E. | |||
| Vol 17, No 4 (2022) | Kikuchi–Fujimoto disease: literature review and report of four cases |
(Rus) |
|
| Potapenko V.G., Baykov V.V., Markova А.Y., Mikhailova N.B., Ter‑Grigoryan A.S., Krivolapov Y.А. | |||
| Vol 17, No 4 (2022) | Resolution of the Expert Council on the issues of diagnosis and treatment of myeloproliferative neoplasms, existing standards and the possibility of their implementation in real clinical practice in Russia |
(Rus) |
|
| Melikyan A.L., Subortseva I.N. | |||
| Vol 17, No 4 (2022) | Langerhans cell histiocytosis in adults: literature review |
(Rus) |
|
| Potapenko V.G., Baykov V.V., Zinchenko A.V., Potikhonova N.A. | |||
| Vol 17, No 4 (2022) | Management of patients with immune thrombocytopenia in the Moscow region |
(Rus) |
|
| Zakharov S.G., Mitina T.A., Vardanyan R.V., Kontievskiy I.N., Faenko A.P., Tekeeva Z.R. | |||
| Vol 17, No 3 (2022) | Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study |
(Rus) |
|
| Potapenko V.G., Baumert E.V., Bobrova A.A., Vashchenkov R.V., Dorofeeva N.V., Kaplanov K.D., Karyagina E.V., Levanov A.N., Luchinin A.S., Moiseev S.I., Novitskii A.V., Nizamutdinova A.S., Pirogova О.V., Povzun S.A., Platonov М.V., Porunova V.V., Ptashnikov D.А., Ryabchikova V.V., Simeniv S.Y., Skorokhod I.А., Ukrainchenko Е.А., Chaginskaya D.А., Shelekhova T.V., Shirokova M.N., Shutylev A.A., Medvedeva N.V. | |||
| Vol 17, No 3 (2022) | According to the materials of the VI Congress of Hematologists of Russia and the III Congress of Transfusiologists of Russia. Immunotherapy for multiple myeloma: from first drugs to overcoming resistance |
(Rus) |
|
| Nikulin Y.A. | |||
| Vol 17, No 3 (2022) | Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2nd line treatment before autologous hematopoietic stem cell transplantation (preliminary results) |
(Rus) |
|
| Mamedova A.A., Mochkin N.E., Sarzhevskiy V.O., Demina E.A., Bogatyrev V.S., Spornik A.A., Samoylova A.A., Rukavitsin A.A., Smirnova E.G., Bannikova A.E., Melnichenko V.Y., Mikhaylova N.B., Borzenkova E.S., Stelmakh L.V., Zalyalov Y.R., Semenova A.A., Tumyan G.S., Danilova M.A., Konova O.A., Falaleeva N.A., Terekhova A.Y., Vernyuk M.A., Chervontseva A.M., Khayrullina L.S., Maslov A.A., Lysenko I.B., Alekseeva Y.A., Pavlyuchenko E.S., Mirsaitov A.A., Zverkova A.A., Ishmatova I.V., Volchenkov S.A., Motalkina M.S., Zyuzgin I.S. | |||
| Vol 17, No 3 (2022) | Modern approaches to the treatment of relapsed follicular lymphoma |
(Rus) |
|
| Ryabukhina Y.E., Abbasbeyli F.M., Zeynalova P.A., Timofeeva O.L., Batsev A.F., Allakhverdieva G.F., Sinitsina O.V., Zhukov A.G. | |||
| Vol 17, No 3 (2022) | According to the materials of the Conference “Algorithms of emergency situations in oncohematology. Approaches and treatment” |
(Rus) |
|
| Ryabukhina Y.E. | |||
| Vol 17, No 2 (2022) | Early progression of follicular lymphoma: a view of the problem and personal experience |
(Rus) |
|
| Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Gushchina E.E., Khayrullina L.S., Fedenko A.A. | |||
| Vol 17, No 2 (2022) | Clinical and molecular-biologic features of infant acute leukemia |
(Rus) |
|
| Korkina Y.S., Valiev T.T., Varfolomeeva S.R. | |||
| Vol 17, No 1 (2022) | The role of pomalidomide in treatment of relapse and refractory multiple myeloma |
(Rus) |
|
| Voloshin S.V., Linnikov S.Y., Garifullin A.D., Kuzyaeva A.A., Shmidt A.V., Kuvshinov A.Y., Bogdanov A.N., Mikhileva M.A., Martynkevich I.S., Zenina M.N., Sidorkevich S.V. | |||
| Vol 17, No 1 (2022) | Advances and perspective of the immunotherapy for relapsed/refractory multiple myeloma (interview) |
(Rus) |
|
| Semochkin S.V. | |||
| Vol 17, No 1 (2022) | Histiocytic neoplasms: modern aspects of pathogenesis, classification, diagnosis and treatment |
(Rus) |
|
| Gurieva O.D., Valiev T.T., Pavlovskaya A.I. | |||
| Vol 17, No 1 (2022) | Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status |
(Rus) |
|
| Karakulov R.K., Kaydarova D.R., Dushimova Z.D., Gabbasova S.T., Sagindykov G.A., Nasipov B.A., Dzhazyltaeva A.S., Kemelbekov N.A. | |||
| Vol 16, No 3 (2021) | Epidemiological and clinical features of lymphoproliferative diseases in the head and neck region |
(Rus) |
|
| Kamolova F.S., Mudunov A.M., Zeynalova P.A., Grivtsova L.Y., Allakhverdieva G.F., Azizyan R.I., Akhundov A.A., Zaderenko I.A., Bolotin M.V., Stelmakh D.K., Sokorutov V.I., Il’kaev K.D., Tsiklauri V.T., Gelfand I.M., Pak M.B., Timofeeva O.L., Ryabukhina Y.E., Abbasbeyli F.M., Chzhao T. | |||
| Vol 16, No 3 (2021) | Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015” |
(Rus) |
|
| Bagova M.O., Magomedova A.U., Kravchenko S.K., Mangasarova Y.K., Margolin O.V., Nesterova E.S., Gorenkova L.G., Misyurina A.E., Fastova E.A., Babaeva F.E., Sychevskaya K.A., Kulikov S.M., Chabaeva Y.A., Savchenko V.G. | |||
| Vol 16, No 3 (2021) | Results of longstanding, single-center trial for pediatric Hodgkin lymphoma treatment |
(Rus) |
|
| Valiev T.T., Belyaeva E.S. | |||
| Vol 16, No 2 (2021) | Treatment of primary central nervous system lymphomas |
(Rus) |
|
| Cherkashina I.V., Vernyuk M.A., Chervontseva A.M., Gushchina E.E., Khayrullina L.S., Lunin V.V., Zeynalova P.A., Fedenko A.A. | |||
| Vol 16, No 2 (2021) | Current trends in pediatric aggressive B-cell lymphomas treatment |
(Rus) |
|
| Korkina Y.S., Valiev T.T. | |||
| Vol 16, No 2 (2021) | Comparative evaluation of the effectiveness of primary treatment regimens in patients with classical Hodgkin’s lymphoma from the group of unfavorable prognosis |
(Rus) |
|
| Chervontseva A.M., Verniuk M.A., Gushchina E.E., Cherkashina I.V., Pavlova O.A., Khayrullina L.S., Fedenko А.А. | |||
| No 3 (2008) | Острый промиелоцитарный лейкоз: новые проблемы и возможные решения |
(Rus) |
|
| . | |||
| No 3 (2008) | Efficiency of therapy for acute promyelocytic leukemia in children, by using all-trance retinoic acid, cytosine arabinoside, and smaller-dose anthracyclines |
(Rus) |
|
| Samochatova E.V., Baidildina D.D., Maschan M.A., Savva N.N., Khlebnikova O.P., Shamardina A.V., Mareiko Y.E., Tsaur G.A., Riger T.O., Shneider M.M., Rumyantseva Y.V., Nasedkina T.V., Savitskaya T.V., Maschan A.A. | |||
| No 3 (2008) | Факторы прогноза и результаты терапии первичной системной анапластической крупноклеточной лимфомы |
(Rus) |
|
| Semenova A.A., Probatova N.A., Sorokin E.N., Timofeeva O.L., Poddubnaya I.V. | |||
| No 3 (2008) | Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol |
(Rus) |
|
| Goroshkova M.Y., Rumyantseva Y.V., Aleinikova O.V., Dudkin S.A., Fechina L.G., Shamardina A.V., Streneva O.V., Kondratchik K.L., Minkina L.M., Lapotentova E.S., Inyushkina E.V., Kozlova O.B., Zhukovskaya E.V., Khlebnikova O.P., Basharova E.V., Timofeeva V.N., Pavlova G.P., Zlobina V.D., Utrobina O.A., Banshchikova E.S., Aslanyan K.S., Kondakova E.V., Tselousova E.V., Myakova N.V., Turobova T.V., Ryskal O.V., Fuks O.Y., Lebedev V.V., Chipsanova N.F., Varfolomeeva S.R., Karachunsky A.I. | |||
| 1 - 53 of 53 Items | |||
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36928 от 21.07.2009.
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36928 от 21.07.2009.